Understanding how spinophilin modulates the phosphorylation status of these substrates in vivo and in specific cell types and how perturbations in spinophilin interactions contribute to pathological changes in striatal MSN spine density associated with PD will greatly enhance our understanding of the pathophysiology of this disorder. The gene discussed is PPP1R9B; the disease is Parkinson disease.